Dr. Thomas Jankowski explained that THIO, a telomerase inhibitor, is being studied with Libtayo to help overcome resistance in advanced lung cancer.
Dr. Thomas Jankowski
Advertisement
Articles by Dr. Thomas Jankowski
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education
2
Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’
3
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
4
What Are My Options for Liver Cancer Treatment?
5
